HIGH TIDE INC (HITI) Fundamental Analysis & Valuation
NASDAQ:HITI • CA42981E4013
Current stock price
2.44 USD
+0.04 (+1.67%)
At close:
2.44 USD
0 (0%)
Pre-Market:
This HITI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. HITI Profitability Analysis
1.1 Basic Checks
- HITI had negative earnings in the past year.
- In the past year HITI had a positive cash flow from operations.
- In the past 5 years HITI always reported negative net income.
- HITI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- HITI has a better Return On Assets (-13.49%) than 63.87% of its industry peers.
- HITI's Return On Equity of -52.89% is in line compared to the rest of the industry. HITI outperforms 50.26% of its industry peers.
- HITI has a better Return On Invested Capital (6.12%) than 83.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.49% | ||
| ROE | -52.89% | ||
| ROIC | 6.12% |
ROA(3y)-11.05%
ROA(5y)-14.75%
ROE(3y)-30.28%
ROE(5y)-32.2%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Operating Margin of HITI (3.11%) is better than 79.06% of its industry peers.
- HITI's Operating Margin has improved in the last couple of years.
- HITI has a Gross Margin (26.05%) which is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of HITI has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.11% | ||
| PM (TTM) | N/A | ||
| GM | 26.05% |
OM growth 3YN/A
OM growth 5Y10.73%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.78%
GM growth 5Y-6.82%
2. HITI Health Analysis
2.1 Basic Checks
- HITI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- HITI has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for HITI has been increased compared to 5 years ago.
- Compared to 1 year ago, HITI has a worse debt to assets ratio.
2.2 Solvency
- HITI has an Altman-Z score of 1.80. This is a bad value and indicates that HITI is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of HITI (1.80) is comparable to the rest of the industry.
- HITI has a debt to FCF ratio of 5.97. This is a neutral value as HITI would need 5.97 years to pay back of all of its debts.
- HITI's Debt to FCF ratio of 5.97 is amongst the best of the industry. HITI outperforms 82.20% of its industry peers.
- HITI has a Debt/Equity ratio of 0.97. This is a neutral value indicating HITI is somewhat dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.97, HITI is doing worse than 75.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | 5.97 | ||
| Altman-Z | 1.8 |
ROIC/WACC0.66
WACC9.25%
2.3 Liquidity
- A Current Ratio of 1.43 indicates that HITI should not have too much problems paying its short term obligations.
- HITI's Current ratio of 1.43 is on the low side compared to the rest of the industry. HITI is outperformed by 76.96% of its industry peers.
- HITI has a Quick Ratio of 1.43. This is a bad value and indicates that HITI is not financially healthy enough and could expect problems in meeting its short term obligations.
- HITI has a Quick ratio of 0.72. This is amonst the worse of the industry: HITI underperforms 87.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.43 | ||
| Quick Ratio | 0.72 |
3. HITI Growth Analysis
3.1 Past
- The earnings per share for HITI have decreased strongly by -519.69% in the last year.
- Looking at the last year, HITI shows a quite strong growth in Revenue. The Revenue has grown by 17.36% in the last year.
- The Revenue has been growing by 48.14% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-519.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.64%
Revenue 1Y (TTM)17.36%
Revenue growth 3Y18.51%
Revenue growth 5Y48.14%
Sales Q2Q%23.57%
3.2 Future
- HITI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.45% yearly.
- Based on estimates for the next years, HITI will show a quite strong growth in Revenue. The Revenue will grow by 11.26% on average per year.
EPS Next Y106.75%
EPS Next 2Y53.04%
EPS Next 3Y38.98%
EPS Next 5Y30.45%
Revenue Next Year23.35%
Revenue Next 2Y17.96%
Revenue Next 3Y16.48%
Revenue Next 5Y11.26%
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. HITI Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for HITI. In the last year negative earnings were reported.
- A Price/Forward Earnings ratio of 15.72 indicates a correct valuation of HITI.
- Based on the Price/Forward Earnings ratio, HITI is valued cheaper than 80.63% of the companies in the same industry.
- HITI's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.75.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 15.72 |
4.2 Price Multiples
- 90.58% of the companies in the same industry are more expensive than HITI, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, HITI is valued cheaper than 86.91% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.56 | ||
| EV/EBITDA | 7.99 |
4.3 Compensation for Growth
- HITI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as HITI's earnings are expected to grow with 38.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y53.04%
EPS Next 3Y38.98%
5. HITI Dividend Analysis
5.1 Amount
- HITI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
HITI Fundamentals: All Metrics, Ratios and Statistics
2.44
+0.04 (+1.67%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Industry Strength30.71
Industry Growth47.76
Earnings (Last)03-17 2026-03-17/amc
Earnings (Next)06-15 2026-06-15
Inst Owners14.06%
Inst Owner Change0.93%
Ins Owners8.58%
Ins Owner ChangeN/A
Market Cap214.48M
Revenue(TTM)629.85M
Net Income(TTM)-46.73M
Analysts80
Price Target5.26 (115.57%)
Short Float %0.79%
Short Ratio1.26
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)0.63%
Min Revenue beat(2)0.29%
Max Revenue beat(2)0.98%
Revenue beat(4)3
Avg Revenue beat(4)0.22%
Min Revenue beat(4)-1.49%
Max Revenue beat(4)1.09%
Revenue beat(8)6
Avg Revenue beat(8)0.25%
Revenue beat(12)9
Avg Revenue beat(12)0.49%
Revenue beat(16)13
Avg Revenue beat(16)7.31%
PT rev (1m)-1.1%
PT rev (3m)-0.49%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)-166.7%
EPS NY rev (1m)-69.69%
EPS NY rev (3m)-68.61%
Revenue NQ rev (1m)-1.92%
Revenue NQ rev (3m)-2.16%
Revenue NY rev (1m)-2.3%
Revenue NY rev (3m)-4.88%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 15.72 | ||
| P/S | 0.47 | ||
| P/FCF | 15.56 | ||
| P/OCF | 10.09 | ||
| P/B | 3.32 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.99 |
EPS(TTM)-0.42
EYN/A
EPS(NY)0.16
Fwd EY6.36%
FCF(TTM)0.16
FCFY6.43%
OCF(TTM)0.24
OCFY9.91%
SpS5.24
BVpS0.74
TBVpS-0.32
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.49% | ||
| ROE | -52.89% | ||
| ROCE | 7.75% | ||
| ROIC | 6.12% | ||
| ROICexc | 7.18% | ||
| ROICexgc | 17.59% | ||
| OM | 3.11% | ||
| PM (TTM) | N/A | ||
| GM | 26.05% | ||
| FCFM | 2.99% |
ROA(3y)-11.05%
ROA(5y)-14.75%
ROE(3y)-30.28%
ROE(5y)-32.2%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y8.85%
ROICexc growth 3YN/A
ROICexc growth 5Y9.97%
OM growth 3YN/A
OM growth 5Y10.73%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.78%
GM growth 5Y-6.82%
F-Score2
Asset Turnover1.82
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | 5.97 | ||
| Debt/EBITDA | 1.86 | ||
| Cap/Depr | 38.53% | ||
| Cap/Sales | 1.62% | ||
| Interest Coverage | 2.48 | ||
| Cash Conversion | 63.05% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.43 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | 1.8 |
F-Score2
WACC9.25%
ROIC/WACC0.66
Cap/Depr(3y)33.59%
Cap/Depr(5y)35.25%
Cap/Sales(3y)1.64%
Cap/Sales(5y)2.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-519.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.64%
EPS Next Y106.75%
EPS Next 2Y53.04%
EPS Next 3Y38.98%
EPS Next 5Y30.45%
Revenue 1Y (TTM)17.36%
Revenue growth 3Y18.51%
Revenue growth 5Y48.14%
Sales Q2Q%23.57%
Revenue Next Year23.35%
Revenue Next 2Y17.96%
Revenue Next 3Y16.48%
Revenue Next 5Y11.26%
EBIT growth 1Y51.49%
EBIT growth 3YN/A
EBIT growth 5Y64.03%
EBIT Next Year593.97%
EBIT Next 3Y135.81%
EBIT Next 5Y73.97%
FCF growth 1Y-0.6%
FCF growth 3YN/A
FCF growth 5Y16.8%
OCF growth 1Y14.26%
OCF growth 3Y74.46%
OCF growth 5Y21.95%
HIGH TIDE INC / HITI Fundamental Analysis FAQ
What is the fundamental rating for HITI stock?
ChartMill assigns a fundamental rating of 4 / 10 to HITI.
What is the valuation status for HITI stock?
ChartMill assigns a valuation rating of 6 / 10 to HIGH TIDE INC (HITI). This can be considered as Fairly Valued.
What is the profitability of HITI stock?
HIGH TIDE INC (HITI) has a profitability rating of 4 / 10.
How financially healthy is HIGH TIDE INC?
The financial health rating of HIGH TIDE INC (HITI) is 3 / 10.